Improvement of synaptic plasticity and cognitive function in RASopathies—a monocentre, randomized, double-blind, parallel-group, placebo-controlled, cross-over clinical trial (SynCoRAS)

Improvement of synaptic plasticity and cognitive function in RASopathies—a monocentre, randomized, double-blind, parallel-group, placebo-controlled, cross-over clinical trial (SynCoRAS)

Abstract Background Cognitive impairment is a common medical issue in rat sarcoma (RAS) pathway disorders, so-called RASopathies, like Neurofibromatosis type 1 (NF1) or Noonan syndrome (NS). It is presumed to be caused by impaired synaptic plasticity. In animal studies, pathway-specific pharmacologi...

Full description

Bibliographic Details
Main Authors: Nikolai H. Jung, Silvia Egert-Schwender, Beate Schossow, Victoria Kehl, Ute Wahlländer, Louisa Brich, Viktoria Janke, Christiane Blankenstein, Martin Zenker, Volker Mall
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Trials
Subjects:
RASopathies
Neurofibromatosis type 1
Noonan syndrome
Transcranial magnetic stimulation
Synaptic plasticity
Attention
Online Access:https://doi.org/10.1186/s13063-023-07392-z

Internet

https://doi.org/10.1186/s13063-023-07392-z

Similar Items